DRUG Bright Minds Biosciences Inc.
Healthcare$86.28+3.33%ClosedMarket Cap: $669.7M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$164.33
Target (Median)
$147.00
Target Range
$126.00 - $220.00
Upside from current price: 90.5%
Rating Distribution
1 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-20 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-03-30 | BTIG | maintain | Buy | Buy |
| 2026-03-04 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-17 | BTIG | maintain | Buy | Buy |
| 2026-01-07 | BTIG | maintain | Buy | Buy |
| 2026-01-02 | Chardan Capital | maintain | Buy | Buy |
| 2025-12-30 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-09-15 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Sep 30 | $-12.87 | $33.6M | 5 |
| Sat Sep 30 | $-14.96 | $0.00 | 6 |
| Sun Sep 30 | $-14.14 | $0.00 | 3 |
| Mon Sep 30 | $-8.73 | $0.00 | 2 |